tradingkey.logo

Ecolab Q4 sales rise 5% on Food & Beverage unit strength

ReutersFeb 10, 2026 1:10 PM


Overview

  • Water solutions firm's Q4 sales rose 5%, slightly beating analyst expectations

  • Adjusted EPS for Q4 beat analyst expectations, rising 15% yr/yr

  • Company expects 2026 adjusted EPS to grow 12% to 15%


Outlook

  • Ecolab expects 2026 adjusted diluted EPS between $8.43 and $8.63, up 12% to 15%

  • Company anticipates 1Q 2026 adjusted diluted EPS between $1.67 and $1.73, up 11% to 15%

  • Ecolab forecasts 2026 organic sales growth of 3% to 4%, accelerating through the year


Result Drivers

  • ORGANIC SALES GROWTH - Ecolab's Q4 results were driven by strong organic sales growth in Food & Beverage, Pest Elimination, and Life Sciences, offsetting challenges in basic industries and Paper

  • OVIVO ACQUISITION - The acquisition of Ovivo Electronics enhanced Ecolab's Global High-Tech business, contributing to Q4 performance

  • PRODUCTIVITY INITIATIVES - One Ecolab productivity initiatives improved operating income margins, contributing to Q4 results


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q4 Sales

Slight Beat*

$4.20 bln

$4.19 bln (16 Analysts)

Q4 Adjusted EPS

Beat

$2.08

$2.07 (21 Analysts)

Q4 EPS

$1.98

*Applies to a deviation of less than 1%; not applicable for per-share numbers.


Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 16 "strong buy" or "buy", 12 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the specialty chemicals peer group is "buy"

  • Wall Street's median 12-month price target for Ecolab Inc is $300.00, about 4.1% above its February 9 closing price of $288.16

  • The stock recently traded at 34 times the next 12-month earnings vs. a P/E of 31 three months ago

Press Release: ID:nBw8MnTxXa

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI